选择尺寸
关于此项目
Quality Level
agency
BP, ChP, JP, Ph. Eur., USP
product line
EMPROVE® API
form
solid
potency
2630 mg/kg LD50, skin (Rat)
pH
4.5-8.5 (20 °C, 50 g/L in H2O)
mp
176 °C (dec.) (lit.)
solubility
soluble
application(s)
liquid formulation
ophthalmics
pharmaceutical
semi-solid formulation
solid formulation
storage temp.
2-25°C
SMILES string
O.O.Cl[Ca]Cl
InChI
1S/Ca.2ClH.2H2O/h;2*1H;2*1H2/q+2;;;;/p-2
InChI key
LLSDKQJKOVVTOJ-UHFFFAOYSA-L
General description
Application
Legal Information
Still not finding the right product?
Explore all of our products under 氯化钙 二水合物
signalword
Warning
hcodes
Hazard Classifications
Eye Irrit. 2
存储类别
13 - Non Combustible Solids
wgk
WGK 1
flash_point_f
Not applicable
flash_point_c
Not applicable
法规信息
此项目有
使用 Emprove® 计划保持符合 GMP 要求
使用Emprove® Dossiers可加快资格认证、保持合规性并节省时间。
注意:您将进入 EmproveSuite.com。您的用户名和密码与 SigmaAldrich.com 是分开的,可能不同。
免费注册,几分钟内即可访问 Emprove® Dossiers。 升级您的订阅计划,解锁 Emprove® Suite 中的高级定制内容。
没有找到您要找的内容?访问 Emprove® 计划帮助页面。
商品
Medicine for children poses unique formulation challenges compared to adults. Consider developmental physiology and age specifics when designing pharmaceuticals. Quality issues can severely impact patient safety. Therefore, excipient quality, supplier selection, and supply chain security are crucial, particularly for pediatric formulations.
相关内容
Developing formulations specifically for infants and children is increasingly important. To help you master these challenges effectively, we offer an extensive portfolio of well-established high-quality excipients and APIs for pediatric pharmaceutical formulations that are proven in practice.
全球贸易项目编号
| 货号 | GTIN |
|---|---|
| 1024659029 | 04027269390556 |
| 1024659525 | 04027269676919 |
| 1024650001 | 04027269430252 |
| 1024651000 | 04054839392184 |
